Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
8158 On Other Exchanges
Symbol
Exchange
8158 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

china regenerative medicine (8158) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHINA REGENERATIVE MEDICINE (8158)

Related News

No related news articles were found.

china regenerative medicine (8158) Related Businessweek News

No Related Businessweek News Found

china regenerative medicine (8158) Details

China Regenerative Medicine International Limited, an investment holding company, is engaged in the research, development, production, and sale of tissue engineering skin related products. The company’s tissue engineering skin products include ActivSkin, which is used to cure injuries due to accidents and diseases occurring from infection, ulcer, burn, complication of surgeries, and congenital abnormalities; and Acellular Cornea for the treatment of various kinds of cornea diseases, including cornea lamellar defect, cornea alkali burn, and bacteria corneal ulcer. Its other development products comprise Selective Acellular Porcine Skin for the treatment of various skin injuries, infected, and deficient wounds, as well as enhance healing of scars and chronic non-healing ulcers and prevent recurrence; and Boactive cosmetics. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is based in Wanchai, Hong Kong.

414 Employees
Last Reported Date: 07/17/15
Founded in 1995

china regenerative medicine (8158) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: $1.2M
Executive Director
Total Annual Compensation: $1.4M
Compliance Officer and Executive Director
Total Annual Compensation: $1.4M
Compensation as of Fiscal Year 2014.

china regenerative medicine (8158) Key Developments

China Regenerative Medicine International Limited Reports Audited Consolidated Earnings Results for the Year Ended April 30, 2015

China Regenerative Medicine International Limited reported audited consolidated earnings results for the year ended April 30, 2015. For the period, the company reported revenue of HKD 2,817,000 compared to HKD 510,000 for the same period a year ago. Loss before income tax was HKD 272,528,000 compared to HKD 275,248,000 for the same period a year ago. Loss for the year was HKD 255,392,000 compared to HKD 271,297,000 a year ago. Loss for the year attributable to owners of the company was HKD 250,098,000 compared to HKD 263,442,000 for the same period a year ago. Basic loss per share was 2.017 cents compared to 2.668 cents a year ago.

China Regenerative Medicine International Limited to Report Fiscal Year 2015 Final Results on Jul 17, 2015

China Regenerative Medicine International Limited announced that they will report fiscal year 2015 final results on Jul 17, 2015

China Regenerative Medicine International Limited, Board Meeting, Jul 17, 2015

China Regenerative Medicine International Limited, Board Meeting, Jul 17, 2015. Agenda: To consider and approve the final results of the company and its subsidiaries for the year ended April 30, 2015; and to consider the payment of a dividend, if any.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8158:HK $0.49 HKD +0.005

8158 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8158.
View Industry Companies
 

Industry Analysis

8158

Industry Average

Valuation 8158 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2,401.9x
Price/Book 4.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2,354.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHINA REGENERATIVE MEDICINE, please visit www.crmi.hk. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.